Clinical Trial Update: Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer [Phase 4]

View source ↗

Summary

Phase IV clinical trial results for eribulin mesylate in Korean patients with metastatic or locally advanced breast cancer have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Breast Neoplasms, Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2016-10-07